Preprints and Publications

2022

Estimating RSV seasonality from pandemic disruptions: a modelling study.
Krauer F, Fjelde TE, Koltai M, Hodgson D, Treskova M, Harvey C, Jit M, Wichmann O, Harder T, Flasche S.
MedRxiv 2022.

Determinants of RSV epidemiology following suppression through pandemic contact restrictions.
Koltai M, Krauer F, Hodgson D, van Leeuwen E, Treskova M, Jit M, Flasche S.
Epidemics 2021 Sep;40:100614. doi: 10.1016/j.epidem.2022.100614. Epub 2022 Jul 21.

Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales.
Hodgson D, Koltai M, Krauer F, Flasche S, Jit M, Atkins KE.
Vaccine. 2022 Oct 31;S0264-410X(22)01300-7. doi: 10.1016/j.vaccine.2022.10.041.

2021

The influence of temperature on the seasonality of historical plague outbreaks.
Krauer F, Viljugrein H, Dean KR.
Proc Biol Sci. 2021 Jul 14;288(1954):20202725. doi: 10.1098/rspb.2020.2725. Epub 2021 Jul 14.

Mapping the plague through natural language processing.
Krauer F, Schmid BV.
MedRxiv 2021.

Outbreaks of publications about emerging infectious diseases: the case of SARS-CoV-2 and Zika virus.
Ipekci AM, Buitrago-Garcia D, Meili KW, Krauer F, Prajapati N, Thapa S, Wildisen L, Araujo-Chaveron L, Baumann L, Shah S, Whiteley T, Solís-García G, Tsotra F, Zhelyazkov I, Imeri H, Low N, Counotte MJ.
BMC Med Res Methodol. 2021 Mar 11;21(1):50. doi: 10.1186/s12874-021-01244-7.

2020

Gimme a break, the pandemic had just started

2019

Epidemiology of a bubonic plague outbreak in Glasgow, Scotland in 1900.
Dean KR, Krauer F, Schmid BV.
R Soc Open Sci. 2019 Jan 2;6(1):181695. doi: 10.1098/rsos.181695. eCollection 2019 Jan.

Reply to Park et al.: Human ectoparasite transmission of plague during the Second Pandemic is still plausible
Dean KR, Krauer F, Walløe L, Lingjærde OC, Bramanti B, Stenseth NC, Schmid BV.
Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):E7894-E7895. doi: 10.1073/pnas.1810221115. Epub 2018.

2018

Human ectoparasites and the spread of plague in Europe during the Second Pandemic.
Dean KR, Krauer F, Walløe L, Lingjærde OC, Bramanti B, Stenseth NC, Schmid BV.
Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):E7894-E7895. doi: 10.1073/pnas.1810221115. Epub 2018

2017

Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barré Syndrome: Systematic Review.
Krauer F, Riesen M, Reveiz L, Oladapo OT, Martínez-Vega R, Porgo TV, Haefliger A, Broutet NJ, Low N; WHO Zika Causality Working Group.
PLoS Med. 2017 Jan 3;14(1):e1002203. doi: 10.1371/journal.pmed.1002203. eCollection 2017 Jan.

2016

Heterogeneity in District-Level Transmission of Ebola Virus Disease during the 2013-2015 Epidemic in West Africa.
Krauer F, Gsteiger S, Low N, Hansen CH, Althaus CL.
PLoS Negl Trop Dis. 2016 Jul 19;10(7):e0004867. doi: 10.1371/journal.pntd.0004867. eCollection 2016 Jul.

Zika Virus as a Cause of Neurologic Disorders.
Broutet N, Krauer F, Riesen M, Khalakdina A, Almiron M, Aldighieri S, Espinal M, Low N, Dye C.
N Engl J Med. 2016 Apr 21;374(16):1506-9. doi: 10.1056/NEJMp1602708. Epub 2016 Mar 9.

2009-2016 Nephrology publications

Renal Blood Oxygenation Level-dependent Imaging in Longitudinal Follow-up of Donated and Remaining Kidneys.
Seif M, Eisenberger U, Binser T, Thoeny HC, Krauer F, Rusch A, Boesch C, Vogt B, Vermathen P.
Radiology. 2016 Jun;279(3):795-804. doi: 10.1148/radiol.2015150370. Epub 2016 Jan 8.

Urinary biomarkers at early ADPKD disease stage.
Petzold K, Poster D, Krauer F, Spanaus K, Andreisek G, Nguyen-Kim TD, Pavik I, Ho TA, Serra AL, Rotar L.
PLoS One. 2015 Apr 13;10(4):e0123555. doi: 10.1371/journal.pone.0123555. eCollection 2015.

Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.
Kistler AD, Serra AL, Siwy J, Poster D, Krauer F, Torres VE, Mrug M, Grantham JJ, Bae KT, Bost JE, Mullen W, Wüthrich RP, Mischak H, Chapman AB.
PLoS One. 2013;8(1):e53016. doi: 10.1371/journal.pone.0053016. Epub 2013 Jan 10.

Low-dose oral sirolimus and the risk of menstrual-cycle disturbances and ovarian cysts: analysis of the randomized controlled SUISSE ADPKD trial.
Braun M, Young J, Reiner CS, Poster D, Krauer F, Kistler AD, Kristanto P, Wang X, Liu Y, Loffing J, Andreisek G, von Eckardstein A, Senn O, Wüthrich RP, Serra AL.
PLoS One. 2012;7(10):e45868. doi: 10.1371/journal.pone.0045868. Epub 2012 Oct 10.

Growth of arachnoid cysts in patients with autosomal dominant polycystic kidney disease: serial imaging and clinical relevance.
Krauer F, Ahmadli U, Kollias S, Bleisch J, Wüthrich RP, Serra AL, Poster D.
Clin Kidney J. 2012 Oct;5(5):405-11. doi: 10.1093/ckj/sfs111.

Soluble klotho and autosomal dominant polycystic kidney disease.
Pavik I, Jaeger P, Ebner L, Poster D, Krauer F, Kistler AD, Rentsch K, Andreisek G, Wagner CA, Devuyst O, Wüthrich RP, Schmid C, Serra AL.
Clin J Am Soc Nephrol. 2012 Feb;7(2):248-57. doi: 10.2215/CJN.09020911. Epub 2011 Dec 22.

Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.
Pavik I, Jaeger P, Kistler AD, Poster D, Krauer F, Cavelti-Weder C, Rentsch KM, Wüthrich RP, Serra AL.
Kidney Int. 2011 Jan;79(2):234-40. doi: 10.1038/ki.2010.375. Epub 2010 Oct 13.

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.
Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, Scheffel H, Weishaupt D, Wüthrich RP.
N Engl J Med. 2010 Aug 26;363(9):820-9. doi: 10.1056/NEJMoa0907419. Epub 2010 Jun 26.

Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease.
Serra AL, Kistler AD, Poster D, Krauer F, Senn O, Raina S, Pavik I, Rentsch K, Regeniter A, Weishaupt D, Wüthrich RP.
Nephrol Dial Transplant. 2009 Nov;24(11):3334-42. doi: 10.1093/ndt/gfp280. Epub 2009 Jun 13.

Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series.
Poster D, Kistler AD, Krauer F, Blumenfeld JD, Rennert H, Weishaupt D, Wüthrich RP, Serra AL.
Am J Kidney Dis. 2009 Sep;54(3):450-8. doi: 10.1053/j.ajkd.2009.03.020. Epub 2009 Jun 10.

Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.
Kistler AD, Poster D, Krauer F, Weishaupt D, Raina S, Senn O, Binet I, Spanaus K, Wüthrich RP, Serra AL.
Kidney Int. 2009 Jan;75(2):235-41. doi: 10.1038/ki.2008.558. Epub 2008 Oct 29.